您使用提示模式 关闭

Cencora, Brazilian depositary receipt (BDR)
BRC1COBDR008, C1CO34

添加股票到 WL
全选 清除所有
Cencora, 国家 — 美国
不存在此交易信息
数据显示法可以选择 图形 | 表格
信息来源 - PJSC“莫斯科交易所”。未经PJSC“莫斯科交易所”授权, 禁止传播一切相关证券信息。版权所有, 违法必究。
信息来源 - PJSC“莫斯科交易所”。未经PJSC“莫斯科交易所”授权, 禁止传播一切相关证券信息。版权所有, 违法必究。
从
到
ADD-IN
Cbonds 加载项 API
债券数据 API
请求认证
需要 访问
在数据库中超过2500个条目, 请细化您的搜索范围
所选期间没有数据

最新价格

探索最全面的数据库

80 万

债券

超过 400

定价来源

8 万

股票

9 千

ETF

以最有效的方式跟踪您的投资组合
债券筛选器
观察列表
Excel 附加组件
请求访问

发行人

简介
Cencora Inc is a pharmaceutical services company serving the United States, Canada and select global markets. The Company distributes a range of pharmaceuticalsgeneric pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to ...
Cencora Inc is a pharmaceutical services company serving the United States, Canada and select global markets. The Company distributes a range of pharmaceuticalsgeneric pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a range of healthcare providers located in the United States, Canada and selected global markets, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical and dialysis clinics, physicians and physician group practices, long-term care and other alternate site pharmacies, and other customers.
显示所有 隐藏
  • 发行人
  • 发行人 / 借款人全称
    Cencora Inc
  • 行业
    批发贸易

IFRS / US GAAP 财务报告

2023
I q 英语
II q 英语
III q 英语
IV q 英语
2022
I q 英语
II q 英语
III q 英语
IV q 英语
2021
I q 英语
II q 英语
III q 英语
IV q 英语
2020
I q 英语
II q 英语
III q 英语
IV q 英语
2019
I q 英语
II q 英语
III q 英语
IV q 英语
2018
I q 英语
II q 英语
III q 英语
IV q 英语
2017
I q 英语
II q 英语
III q 英语
IV q 英语
2016
I q 英语
II q 英语
III q 英语
IV q 英语
2015
I q 英语
II q 英语
III q 英语
IV q 英语
2014
IV q 英语
显示全部 隐藏
请求认证
需要 访问

标识符

新闻

2024-04-17 Cencora: Entry Into Material Definitive Agreement, Creation Of Direct Financial Obligation Or An Obligation Under An Offbalance Sheet Arrangement Of A Registrant, Financial Statements And Exhibits
2024-03-28 Moody's Investors Service revised outlook on Cencora to positive and affirmed at "Baa2" (LT- local currency) credit rating
2024-03-12 Cencora: Amendment To Articles Of Incorporation Or Bylaws, Submission Of Matters To A Vote Of Security Holders, Financial Statements And Exhibits
2024-03-11 Cencora: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangement Of Certain Officers, Regulation Fd Disclosure, Financial Statements And Exhibits
2024-03-11 Cencora: Of The Current Report On Form 8k Filed On March 12, 2024 (the Original Form 8k ) By Cencora, Inc. (the Company ), Which Disclosed (i) That Steven H. Collis Will Retire From The Role Of Chief Executive Officer ( Ceo ) Effective October 1, 2024 (the Effective Date ) And Become Executive Chairman Of The Board Of Directors Of The Company (the Board ) As Of Such Date And (ii) The Appointment Of Robert P. Mauch As The Company S President And Ceo, As Of The Effective Date, At Which Time Mr. Mauch Will Also Join The Board. The Sole Purpose Of This Amendment Is To Provide Messrs. Collis And Mauch S Compensation Arrangements In Connection With Their New Positions As Of The Effective Date, Financial Statements And Exhibits
所有机构分析

其他股票和票据

发行人发行的欧洲债券和国内债券

机构持有者

行业领先者

你必须 注册 才能获得访问权